Skip to contentE
Enveric Biosciences, Inc.
E
ENVBEnveric Biosciences, Inc. Q1 2016 · 10-Q
Revenue$7.01M$7.01Mno prior Q1 2015 on file Net Income-$1.16M-$1.16Mno prior Q1 2015 on file EPS Diluted-$0.09-$0.09no prior Q1 2015 on file The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Enveric Biosciences, Inc. · CIK 890821 · Engraved from SEC EDGAR
Operating Cash Flow-$1,565,640— Margins · derivedGross margin44.9%
Operating margin-14.0%
Net margin-16.5%
ended Mar 31, 2016 · filed May 16, 2016 · 46 d after period end